financetom
Business
financetom
/
Business
/
Tata-Mistry case: SC stays NCLAT order rejecting RoC please seeking modification
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata-Mistry case: SC stays NCLAT order rejecting RoC please seeking modification
Jan 24, 2020 2:56 AM

The Supreme Court has ordered a stay on the NCLAT’s order dismissing the Registrar of Companies plea seeking modification of verdict in Cyrus Mistry’s case against Tata Sons.

A three-judge bench comprising Chief Justice S A Bobde, Justices B R Gavai and Surya Kant agreed to hear the matter, along with the main plea filed by Tata Sons against NCLAT's verdict.

The SC has issued notices to the concerned parties.

The NCLAT in its December 18 order termed the conversion of Tata Sons from a public limited to a private limited company “illegal” and asked for a reversal of the decision.

RoC had filed an urgent application seeking modifications to the judgement, including deletion of the word “illegal” in reference to the conversion.

The MCA requested the NCLAT to amend the order to correctly reflect the conduct of RoC Mumbai as not ‘illegal’ but as per the provisions of the Companies Act, 1956/2013.

Also, the MCA sought amendments to delete the aspersions made in the order regarding any hurried help by the ROC Mumbai to Tata Sons, except what was statutorily required.

The NCLAT on January 6 dismissed the RoC’s plea. The tribunal, however, clarified that its judgement had neither cast aspersions on the RoC nor ascribed any mala fide intention to it.

First Published:Jan 24, 2020 11:56 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna says its RSV shot is 50% effective across a second season
Moderna says its RSV shot is 50% effective across a second season
Jun 26, 2024
NEW YORK, June 26 (Reuters) - Moderna Inc ( MRNA ) respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday. In their clinical trials, GSK's RSV vaccine Arexvy was 78% effective in preventing severe RSV over a second year and Pfizer's was 78% effective midway through a second RSV...
HP Appoints Karen Parkhill Finance Chief
HP Appoints Karen Parkhill Finance Chief
Jun 26, 2024
09:31 AM EDT, 06/26/2024 (MT Newswires) -- HP (HPQ) said Wednesday it has appointed Karen Parkhill as chief financial officer, effective Aug. 5. Parkhill will join the company from Medtronic ( MDT ) , where she served as executive vice president and CFO since 2016, HP added. HP's Interim CFO Tim Brown will return to his role as the head...
General Mills Fiscal Fourth-Quarter Sales Fall On Volume, Price Headwinds
General Mills Fiscal Fourth-Quarter Sales Fall On Volume, Price Headwinds
Jun 26, 2024
09:33 AM EDT, 06/26/2024 (MT Newswires) -- General Mills' ( GIS ) sales fell in the fiscal fourth quarter amid lower volume and pricing headwinds as the Cheerios maker provided a weak full-year earnings outlook. The packaged foods maker's adjusted earnings came in at $1.01 a share for the quarter ended May 26, down from $1.12 the year before, but...
Medtronic says CFO Karen Parkhill to depart to join HP
Medtronic says CFO Karen Parkhill to depart to join HP
Jun 26, 2024
June 26 (Reuters) - Medtronic ( MDT ) said on Wednesday its Chief Financial Officer Karen Parkhill will resign from the company to accept a similar role at HP Inc. ( HPQ ) Parkhill will continue to serve as CFO until Aug. 2, while the company evaluates internal and external candidates to replace her. Gary Corona, senior vice president, global...
Copyright 2023-2026 - www.financetom.com All Rights Reserved